Erratum to: The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b+ Ly6Chi cells to tumor tissue reduces tumor growth
© The Author(s). 2016
Received: 28 July 2016
Accepted: 28 July 2016
Published: 8 August 2016
The original article was published in BMC Cancer 2016 16:440
After publication of this work , it was noted that co-author Sahar Tahvili was inadvertently missed from the author list. This has been corrected here, and in the original article. The publisher would like to apologize for any inconvenience this oversight may have caused.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Deronic A, Tahvili S, Leanderson T, Ivars F. The anti-tumor effect of the quinoline-3-carboxamide tasquinimod: blockade of recruitment of CD11b + Ly6Chi cells to tumor tissue reduces tumor growth. BMC Cancer. 2016;16:440. doi:https://doi.org/10.1186/s12885-016-2481-0.View ArticlePubMedPubMed CentralGoogle Scholar